TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2016

Conditions
Cerebral Infarction
Interventions
OTHER

Usual care patients in neurology department

patients characteristics, history, clinical signs chronology and usual medical care by the emergency units, cerebral infarction area

BIOLOGICAL

blood and urines sampling

Collection samples for biochemical determinations of serotonin pathway and kynurenine pathway parameters determinations

PROCEDURE

Psychiatric evaluation

depression scale, impulsivity scale, hostility scale , tobacco consumption questioning

Trial Locations (1)

78150

Centre Hospitalier de Versailles, Le Chesnay

All Listed Sponsors
lead

Versailles Hospital

OTHER

NCT02963545 - TSK (Tryptophan - Serotonin - Kynurenine) Biomarkers Assessment in Stroke | Biotech Hunter | Biotech Hunter